TREOCAPA: Prophylactic treatment of the ductus arterious in preterm infants by acetaminophen.
An international trial conducted in more than 60 centres of 17 European countries. TREOCAPA tries to find out whether the preventive use of paracetamol in preterm infants during the first five days of life is safe and effective to close the ductus arteriosus blood vessel and reduces the risk of prematurity associated complications.
Phase 3 recruitment status: TREOCAPA is now recruiting for the phase III trial. The objective is to recruit 794 children.